08.07.2015 • NewsDede Willamscapacity expansionEvonik

Evonik Expands C4 Output at Antwerp and Marl

German chemical producer Evonik has increased production capacity for C4 products at its sites in Antwerp, Belgium, and Marl, Germany.

The investment, said to be in the triple-digit million euro range, includes additional capability to produce butadiene, the plasticizer isononanol and the antiknock agent MTBE.

In announcing the plans two years ago, Evonik said the expansion would be a step toward lifting its butadiene output in Antwerp by 100,000 t/y, and its output of MTBE at Marl and Antwerp together would rise by 150,000 t/y up to 2015.

Citing market analyses that global demand is increasing by 2-5% annually, the Essen-based company said it is “sustainably strengthening” its market positions and supporting its customers growth plans.

Evonik said it has secured raw materials supply to the new production facilities with long-term contracts. Additionally, for the first time it has made FCC-C4 material flows from refineries usable.

Along with being “a globally leading provider” of the products being expanded as well as other C-4 products, including isobutene, 1-butene, 2-PH (2-propylheptanol) and the plasticizer DINP (diisononylphthalate), the German chemical producer also operates integrated large-scale plants for processing C4 starting materials.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.